Error: Could not add to watchlist. X

Credit Suisse Lux Biotechnology Equity Fund

+ Watchlist
CLTLU:LX
Luxembourg
498.15
USD
0.00
0.00%
As of 08:35:38 ET on 07/03/2015.
Volume
0
Previous Close
498.15
52Wk Range
325.58 - 518.84
1 Yr Return
40.33%
NAV (on -)
-
Total Assets (m USD) (on 07/02/2015)
260.786
Inception Date
-
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
IRENE BEATRICE PUETTNER
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
-
3 Mo Return
4.29%
3 Yr Return
37.33%
5 Yr Return
34.60%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 172.48 k 19.36 m 7.38
Biogen Inc 47.00 k 18.66 m 7.11
Amgen Inc 105.97 k 16.56 m 6.31
Celgene Corp 140.28 k 16.05 m 6.12
Incyte Corp 130.00 k 14.32 m 5.46
BioMarin Pharmaceutical Inc 109.44 k 13.74 m 5.24
Regeneron Pharmaceuticals Inc 25.00 k 12.81 m 4.89
Vertex Pharmaceuticals Inc 85.00 k 10.90 m 4.16
Medivation Inc 80.00 k 10.56 m 4.03
Alexion Pharmaceuticals Inc 52.75 k 8.64 m 3.30
Profile
Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
ADDRESS
Credit Suisse AG
PHONE
-